Axsome Therapeutics, Inc. · 16 hours ago
Senior Manager, Patient Advocacy
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. They are seeking a Senior Manager, Patient Advocacy to drive communications and engagement with patient advocacy organizations and other external stakeholders.
BiopharmaBiotechnologyTherapeutics
Responsibilities
Create and implement strategic plans for patient advocacy and stakeholder engagement
Serve as the primary point of accountability to develop long-term, trusting relationships with patient advocacy community
Collaborate with corporate communications, marketing, market access, medical affairs, and clinical operations on opportunities to engage patients and advocates on key priorities
Support launch readiness and post-marketing insight gathering to ensure positive patient experience
Represent company at advocate events, scientific congresses, and patient meetings
Develop and manage budget for patient advocacy sponsorships and partnership opportunities
Ensure compliance with corporate policies and procedures as well as applicable laws and regulations
Qualification
Required
Bachelor's degree required and minimum of 7 years of experience with patient advocacy groups in a relevant pharmaceutical, non-profit, or consulting setting
Proven track record in managing relationships and influencing key stakeholders
Strong working knowledge of pharmaceutical environment is required
Ability to work onsite Mondays, Tuesday, and Thursdays
Experience forming partnerships with patient advocacy organizations and other external stakeholders
Experience with CNS or other chronic conditions
Excellent written and communication skills
Comfortable multi-tasking in a fast-paced environment and able to adjust based on changing priorities
Willingness to travel as needed, up to 25%
Preferred
Experience in health policy or government affairs preferred
Benefits
Annual bonus
Significant equity
Generous benefits package
Company
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc.
Funding
Current Stage
Public CompanyTotal Funding
$1B2025-05-13Post Ipo Debt· $570M
2023-06-28Post Ipo Equity· $225M
2019-12-23Post Ipo Equity· $200M
Recent News
2026-01-22
Clinical Trials Arena
2026-01-17
Company data provided by crunchbase